Skip to main content
Erschienen in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01.12.2019 | Letter to the Editor

Satellite cell content in Huntington’s disease patients in response to endurance training

verfasst von: Sandro Manuel Mueller, Violeta Mihaylova, Sebastian Frese, Jens A. Petersen, Maria Ligon-Auer, David Aguayo, Martin Flück, Hans H. Jung, Marco Toigo

Erschienen in: Orphanet Journal of Rare Diseases | Ausgabe 1/2019

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Skeletal muscle wasting is a hallmark of Huntington’s disease (HD). However, data on myocellular characteristics and myofiber remodeling in HD patients are scarce. We aimed at gaining insights into myocellular characteristics of HD patients as compared to healthy controls at rest and after a period of increased skeletal muscle turnover.

Methods

Myosin heavy chain (MyHC)-specific cross-sectional area, satellite cell content, myonuclear number, myonuclear domain, and muscle fiber type distribution were determined from vastus lateralis muscle biopsies at rest and after 26 weeks of endurance training in HD patients and healthy controls.

Results

At the beginning of the study, there were no differences in myocellular characteristics between HD patients and healthy controls. Satellite cell content per MyHC-1 fiber (P = 0.014) and per MyHC-1 myonucleus (P = 0.006) increased significantly in healthy controls during the endurance training intervention, whereas it remained constant in HD patients (P = 0.804 and P = 0.975 for satellite cell content per MyHC-1 fiber and myonucleus, respectively). All further variables were not altered during the training intervention in HD patients and healthy controls.

Conclusions

Similar skeletal muscle characteristics between HD patients and healthy controls at baseline suggested similar potential for myofiber remodeling in response to exercise. However, the missing satellite cell response in MyHC-1 myofibers following endurance training in HD patients points to a potential dysregulation in the exercise-induced activation and/or proliferation of satellite cells. In the longer-term, impaired myonuclear turnover might be associated with the clinical observation of skeletal muscle wasting.
Hinweise
Hans H. Jung and Marco Toigo contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
HD
Huntington’s disease
MyHC
Myosin heavy chain

Main text

Huntington’s disease (HD) is a neurodegenerative disorder with symptoms encompassing motor, cognitive, and psychiatric dysfunctions. While the initial research on this disease focused mainly on the central nervous system, other organs and tissues, such as skeletal muscle, have additionally gained attention in the scientific literature in the past few years. For example, several studies in HD patients reported energy metabolism dysfunctions in skeletal muscle [14] and skeletal muscle pathology was well-described in mouse models [57]. Because skeletal muscle wasting is regarded as a hallmark of HD, skeletal muscle mass was also investigated in recent publications. In these studies, no differences in whole-body fat-free mass or lean mass between HD patients and healthy controls could be detected [811]. These findings challenge the notion of skeletal muscle wasting, at least in early- to mid-stage HD patients. Moreover, data on muscle fiber cross-sectional areas, satellite cells, myonuclei, and myofiber remodeling upon exercise in HD patients remain scarce.
In the current preliminary study, we aimed at gaining insights into muscle fiber cross-sectional areas, satellite cell content, myonuclear content and myonuclear number of HD patients as compared to healthy controls at rest and after a period of increased skeletal muscle turnover. We reanalyzed muscle biopsy samples from a previous study [12]. Due to limitations in muscle tissue amount, we were not able to analyze all samples of the previous study. Muscle samples of nine HD patients (age: 51.7 ± 7.9 years, height: 1.74 ± 0.05 m, body mass: 75.9 ± 11.2 kg) and ten healthy control participants (age: 50.0 ± 6.7 years, height: 1.79 ± 0.05 m, body mass: 82.8 ± 13.0 kg) could be analyzed and the results thereof are presented in this report. According to the clinical assessments, the HD patients were classified as early- and intermediate-stage of disease. Myosin heavy chain (MyHC)-specific cross-sectional area, satellite cell content, myonuclear number, and myonuclear domain were determined from vastus lateralis muscle biopsies at rest and after 26 weeks of endurance training in HD patients and healthy controls (Fig. 1). An additional muscle biopsy sample was obtained from HD patients 26 weeks before beginning of the training intervention to assess alterations due to the natural disease progress.
At the beginning of the study, there were no differences in myocellular characteristics between HD patients and healthy controls (Fig. 2). Satellite cell content per MyHC-1 fiber (P = 0.014) and per MyHC-1 myonucleus (P = 0.006) increased significantly in healthy controls during the endurance training intervention, whereas it remained constant in HD patients (P = 0.804 and P = 0.975 for satellite cell content per MyHC-1 fiber and myonucleus, respectively). There was a significant group x time interaction for satellite cells per MyHC-1 myonucleus (P = 0.045). All further variables were not altered during the training intervention in HD patients and healthy controls. During the natural course observation period in HD patients, there were no fiber type-specific alterations in any variable.
Similar skeletal muscle characteristics between HD patients and healthy controls at baseline suggested similar potential for myofiber remodeling in response to exercise and indicated that these characteristics are not affected by pathological processes in the early- and mid-stage of the disease. This observation was further supported by the constant myocellular characteristics during the half-year natural course observation period. However, the missing satellite cell response in MyHC-1 myofibers following a half-year endurance training intervention in HD patients pointed to a potential dysregulation in the exercise-induced activation and/or proliferation of satellite cells. Due to the absence of new genetic material to replace damaged DNA, tissue remodeling might be impaired in subsequent years, resulting in an attenuation of myofiber regeneration. In conclusion, our result points to impaired myonuclear turnover in HD patients that might be associated with the clinical observation of skeletal muscle wasting in the longer-term.

Acknowledgements

We are grateful to all patients and participants for their contribution to this study. The authors kindly thank H. Fischer and E. Osuna for their support during data analysis. Imaging was performed with equipment maintained by the Centre for Microscopy and Image Analysis, University of Zurich.
All patients and participants had completed a routine health questionnaire and were informed about the applied procedures and the associated risks. Patients and participants provided written informed consent for participation in the study. All experiments were approved by the local ethics committee and the study was performed in accordance with the ethical standards laid down in the Declarations of Helsinki for human experimentation. This trial was registered on ClinicalTrials.​gov (NCT01879267).
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Arenas J, Campos Y, Ribacoba R, et al. Complex I defect in muscle from patients with Huntington’s disease. Ann Neurol. 1998;43:397–400.CrossRef Arenas J, Campos Y, Ribacoba R, et al. Complex I defect in muscle from patients with Huntington’s disease. Ann Neurol. 1998;43:397–400.CrossRef
2.
Zurück zum Zitat Gehrig SM, Petersen JA, Frese S, et al. Skeletal muscle characteristics and mitochondrial function in Huntington's disease patients. Mov Disord. 2017;32:1258–9.CrossRef Gehrig SM, Petersen JA, Frese S, et al. Skeletal muscle characteristics and mitochondrial function in Huntington's disease patients. Mov Disord. 2017;32:1258–9.CrossRef
3.
Zurück zum Zitat Lodi R, Schapira AH, Manners D, et al. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol. 2000;48:72–6.CrossRef Lodi R, Schapira AH, Manners D, et al. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol. 2000;48:72–6.CrossRef
4.
Zurück zum Zitat Saft C, Zange J, Andrich J, et al. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov Disord. 2005;20:674–9.CrossRef Saft C, Zange J, Andrich J, et al. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease. Mov Disord. 2005;20:674–9.CrossRef
5.
Zurück zum Zitat Zielonka D, Piotrowska I, Marcinkowski JT, Mielcarek M. Skeletal muscle pathology in Huntington’s disease. Front Physiol. 2014;5:380.CrossRef Zielonka D, Piotrowska I, Marcinkowski JT, Mielcarek M. Skeletal muscle pathology in Huntington’s disease. Front Physiol. 2014;5:380.CrossRef
6.
Zurück zum Zitat Mielcarek M, Smolenski RT, Isalan M. Transcriptional signature of an altered purine metabolism in the skeletal muscle of a Huntington’s disease mouse model. Front Physiol. 2017;8:127.CrossRef Mielcarek M, Smolenski RT, Isalan M. Transcriptional signature of an altered purine metabolism in the skeletal muscle of a Huntington’s disease mouse model. Front Physiol. 2017;8:127.CrossRef
7.
Zurück zum Zitat Mielcarek M, Isalan M. A shared mechanism of muscle wasting in cancer and Huntington’s disease. Clin Transl Med. 2015;4:34.CrossRef Mielcarek M, Isalan M. A shared mechanism of muscle wasting in cancer and Huntington’s disease. Clin Transl Med. 2015;4:34.CrossRef
8.
Zurück zum Zitat Cubo E, Rivadeneyra J, Gil-Polo C, Armesto D, Mateos A, Mariscal-Pérez N. Body composition analysis as an indirect marker of skeletal muscle mass in Huntington’s disease. J Neurol Sci. 2015;358:335–8.CrossRef Cubo E, Rivadeneyra J, Gil-Polo C, Armesto D, Mateos A, Mariscal-Pérez N. Body composition analysis as an indirect marker of skeletal muscle mass in Huntington’s disease. J Neurol Sci. 2015;358:335–8.CrossRef
9.
Zurück zum Zitat Frese S, Petersen JA, Ligon-Auer M, et al. Exercise effects in Huntington disease. J Neurol. 2017;264:32–9.CrossRef Frese S, Petersen JA, Ligon-Auer M, et al. Exercise effects in Huntington disease. J Neurol. 2017;264:32–9.CrossRef
10.
Zurück zum Zitat Pratley RE, Salbe AD, Ravussin E, Caviness JN. Higher sedentary energy expenditure in patients with Huntington’s disease. Ann Neurol. 2000;47:64–70.CrossRef Pratley RE, Salbe AD, Ravussin E, Caviness JN. Higher sedentary energy expenditure in patients with Huntington’s disease. Ann Neurol. 2000;47:64–70.CrossRef
11.
Zurück zum Zitat Süssmuth SD, Müller VM, Geitner C, et al. Fat-free mass and its predictors in Huntington’s disease. J Neurol. 2015;262:1533–40.CrossRef Süssmuth SD, Müller VM, Geitner C, et al. Fat-free mass and its predictors in Huntington’s disease. J Neurol. 2015;262:1533–40.CrossRef
12.
Zurück zum Zitat Mueller SM, Gehrig SM, Petersen JA, et al. Effects of endurance training on skeletal muscle mitochondrial function in Huntington disease patients. Orph J Rare Dis. 2017;12:184.CrossRef Mueller SM, Gehrig SM, Petersen JA, et al. Effects of endurance training on skeletal muscle mitochondrial function in Huntington disease patients. Orph J Rare Dis. 2017;12:184.CrossRef
Metadaten
Titel
Satellite cell content in Huntington’s disease patients in response to endurance training
verfasst von
Sandro Manuel Mueller
Violeta Mihaylova
Sebastian Frese
Jens A. Petersen
Maria Ligon-Auer
David Aguayo
Martin Flück
Hans H. Jung
Marco Toigo
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
Orphanet Journal of Rare Diseases / Ausgabe 1/2019
Elektronische ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-019-1115-4

Weitere Artikel der Ausgabe 1/2019

Orphanet Journal of Rare Diseases 1/2019 Zur Ausgabe